Thyrocare Q1 FY27 results: revenue up 26%, PAT up 39% YoY

Revenue Growth 20pctPat Growth 25pctExceptional ItemResults View source PDF

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+7.0%1-day move

₹544.95

prior close

₹560.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+5.4+3.1+1.3+4.2+7.0—————————

Up moveDown movePending

AI summary

Thyrocare Tech Q1 FY27: Standalone revenue Rs 225.66 Cr, up 26% YoY. PAT rose 39% YoY to Rs 50.17 Cr. Consolidated revenue Rs 240.02 Cr (up 24%), PAT Rs 51.33 Cr (up 34%). EPS Rs 3.15. Board re-appointed Ernst & Young as Internal Auditor for FY27. Auditors gave unmodified conclusion.

Likely market impact

Strong Q1 with double-digit revenue and profit growth; positive momentum for shareholders.